BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34630502)

  • 21. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
    Peng WX; Huang JG; Yang L; Gong AH; Mo YY
    Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m
    Wang X; Zhi M; Zhao W; Deng J
    IUBMB Life; 2024 Jan; ():. PubMed ID: 38265150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
    Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
    Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
    Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 26. Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant,
    Makhafola TJ; Mbele M; Yacqub-Usman K; Hendren A; Haigh DB; Blackley Z; Meyer M; Mongan NP; Bates DO; Dlamini Z
    Front Oncol; 2020; 10():547392. PubMed ID: 33163396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.
    Alarcón CR; Goodarzi H; Lee H; Liu X; Tavazoie S; Tavazoie SF
    Cell; 2015 Sep; 162(6):1299-308. PubMed ID: 26321680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m
    Zheng R; Yu Y; Lv L; Zhang Y; Deng H; Li J; Zhang B
    Exp Cell Res; 2023 Mar; 424(1):113487. PubMed ID: 36693492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HnRNPA2B1 ISGylation Regulates m6A-Tagged mRNA Selective Export via ALYREF/NXF1 Complex to Foster Breast Cancer Development.
    Jin T; Yang L; Chang C; Luo H; Wang R; Gan Y; Sun Y; Guo Y; Tang R; Chen S; Meng D; Dai P; Liu M
    Adv Sci (Weinh); 2024 Jun; 11(24):e2307639. PubMed ID: 38626369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00355 promotes gastric carcinogenesis by scaffolding p300 to activate CDC42 transcription and enhancing HNRNPA2B1 to stabilize CDC42 mRNA dependent on m6A.
    Chen H; Xiao L; Xie G; Zhang P; Dong P; Bian B; Wang J; Zhou Y; Ma Y; Liu Y; Shen L
    Mol Carcinog; 2024 Mar; 63(3):430-447. PubMed ID: 37983727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer.
    Luo J; Zheng J; Hao W; Zeng H; Zhang Z; Shao G
    Oncol Lett; 2021 Jun; 21(6):471. PubMed ID: 33907581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particulate matters 2.5 induce tumor progression in lung cancer by increasing the activity of hnRNPA2B1 resulting in retarding mRNA decay of oxidative phosphorylation.
    Bian W; Yu H; Zhang X; Wang Y; Ni B
    IUBMB Life; 2024 Mar; ():. PubMed ID: 38450584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
    Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
    Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m
    Liu R; Zhong Y; Chen R; Chu C; Liu G; Zhou Y; Huang Y; Fang Z; Liu H
    Theranostics; 2022; 12(18):7760-7774. PubMed ID: 36451863
    [No Abstract]   [Full Text] [Related]  

  • 37. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.
    Wang H; Liang L; Dong Q; Huan L; He J; Li B; Yang C; Jin H; Wei L; Yu C; Zhao F; Li J; Yao M; Qin W; Qin L; He X
    Theranostics; 2018; 8(10):2814-2829. PubMed ID: 29774077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis.
    Li T; Gu M; Deng A; Qian C
    Cancer Cell Int; 2020; 20():239. PubMed ID: 32549786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Xiang S; Liang X; Yin S; Liu J; Xiang Z
    Am J Transl Res; 2020; 12(5):1789-1806. PubMed ID: 32509177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis.
    Liu B; Jiang HY; Yuan T; Luo J; Zhou WD; Jiang QQ; Wu D
    Front Oncol; 2021; 11():650054. PubMed ID: 34277403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.